Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Haemodialysis, blood pressure and risk: at the limit of non-randomized evidence.


Ng SYA. et al, (2020), Nephrol Dial Transplant

In type 2 diabetes, SGLT-2 inhibitors reduce risk for major kidney outcomes.

Journal article

Ai Ng SY. et al, (2020), Ann Intern Med, 172

Accelerometer-measured physical activity and functional behaviours among people on dialysis

Journal article

Nawab K. et al, (2020), Clinical Kidney Journal

Apolipoprotein B, Triglyceride-Rich Lipoproteins, and Risk of Cardiovascular Events in Persons with CKD.

Journal article

Lamprea-Montealegre JA. et al, (2019), Clin J Am Soc Nephrol

Kidney disease trials for the 21st century: innovations in design and conduct.

Journal article

Herrington WG. et al, (2019), Nat Rev Nephrol

General and Abdominal Adiposity and Mortality in Mexico City: A Prospective Study of 150 000 Adults.

Journal article

Gnatiuc L. et al, (2019), Ann Intern Med, 171, 397 - 405

Cost-effectiveness of lipid lowering with statins and ezetimibe in chronic kidney disease.

Journal article

Schlackow I. et al, (2019), Kidney Int, 96, 170 - 179

Chronic kidney disease, heart failure and neprilysin inhibition.

Journal article

Haynes R. et al, (2019), Nephrol Dial Transplant

Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials.

Journal article

Cholesterol Treatment Trialists' Collaboration None., (2019), Lancet, 393, 407 - 415

Effects of Sacubitril/Valsartan Versus Irbesartan in Patients With Chronic Kidney Disease.

Journal article

Haynes R. et al, (2018), Circulation, 138, 1505 - 1514

Authors' Reply.

Journal article

Herrington WG. et al, (2018), J Am Soc Nephrol, 29, 2602 - 2603

Load More